CBCédric Bossard

Cédric Bossard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cédric Bossard has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Jonathan Lao

    Université Clermont Auvergne, CNRS/IN2P3, Laboratoire de Physique de Clermont, 4 Avenue Blaise Pascal, 63178 Aubière (Clermont-Ferrand), France

    4 shared publications
  • Edouard Jallot

    Université Clermont Auvergne, CNRS/IN2P3, Laboratoire de Physique de Clermont, 4 Avenue Blaise Pascal, 63178 Aubière (Clermont-Ferrand), France

    3 shared publications
  • Anne-Margaux Collignon

    Descartes University of Paris Faculty of Dental Surgery, Laboratoires Pathologies, Imagerie et Biothérapies Orofaciales,1 Rue Maurice Arnoux, Montrouge, Île-De-France 92120, France

    2 shared publications
  • Fabien Wauquier

    INRAE, Human Nutrition Unit (UNH), ECREIN Team, TSA 50400, 28 Place Henri Dunant, Clermont-Ferrand, Auvergne-Rhone-Alpes 63001, France

    2 shared publications
  • Henri Granel

    INRA, UMR 1019, UNH, CRNH Auvergne, F-63009 Clermont-Ferrand, France

    2 shared publications
  • Valérie Montouillout

    CNRS, UPR 3079, CEMHTI, 1D Avenue de la Recherche Scientifique, 45071 Orléans Cedex 02, France

    2 shared publications

Latest Publications

  • Open Access

    Zinc-Doped Bioactive Glass/Polycaprolactone Hybrid Scaffolds Manufactured by Direct and Indirect 3D Printing Methods for Bone Regeneration

    by Nafise Elahpour, Isabella Niesner, Cédric Bossard, Nora Abdellaoui, Valérie Montouillout, Franck Fayon, Christine Taviot-Guého, Tina Frankenbach, Alexander Crispin, Pardis Khosravani, et al.

    A novel organic–inorganic hybrid, based on SiO2-CaO-ZnO bioactive glass (BG) and polycaprolactone (PCL), associating the highly bioactive and versatile bioactive glass with clinically established PCL was examined. The BG–PCL hybrid is obtained by acid-catalyzed silica sol–gel process inside PCL solution either by direct or indirect printing. Apatite-formation tests in simulated body fluid (SBF) confirm the ion release along with the hybrid’s bone-like apatite forming. Kinetics differ significantly between directly and indirectly printed scaffolds, the former requiring longer periods to degrade, while the latter demonstrates faster calcium phosphate (CaP) formation. Remarkably, Zn diffusion and accumulation are observed at the surface within the newly formed active CaP layer. Zn release is found to be dependent on printing method and immersion medium. Investigation of BG at the atomic scale reveals the ambivalent role of Zn, capable of acting both as a network modifier and as a network former linking the BG silicate network. In addition, hMSCs viability assay proves no cytotoxicity of the Zn hybrid. LIVE/DEAD staining demonstrated excellent cell viability and proliferation for over seven weeks. Overall, this hybrid material either non-doped or doped with a metal trace element is a promising candidate to be translated to clinical applications for bone regeneration.


  • Bioactive glass-based organic/inorganic hybrids: an analysis of the current trends in polymer design and selection

    by Lukas Gritsch, Cédric Bossard, Edouard Jallot, Julian R. Jones, Jonathan Lao

    Review of the most promising strategies to prepare bioactive glass-based hybrids offering a thorough discussion of key advances in terms of functional and biological performance and a comprehensive summary of all polymers used in hybrids to date.


  • Open Access

    Osteogenic Effect of Fisetin Doping in Bioactive Glass/Poly(caprolactone) Hybrid Scaffolds

    by Henri Granel, Cédric Bossard, Anne-Margaux Collignon, Fabien Wauquier, Julie Lesieur, Gael Y. Rochefort, Edouard Jallot, Jonathan Lao, Yohann Wittrant

    Treating large bone defects or fragile patients may require enhancing the bone regeneration rate to overcome a weak contribution from the body. This work investigates the osteogenic potential of nutrient fisetin, a flavonoid found in fruits and vegetables, as a doping agent inside the structure of a SiO2-CaO bioactive glass-poly(caprolactone) (BG-PCL) hybrid scaffold. Embedded in the full mass of the BG- PCL hybrid during one-pot synthesis, we demonstrate fisetin to be delivered sustainably; the release follows a first-order kinetics with active fisetin concentration being delivered for more than 1 month (36 days). The biological effect of BG-PCL-fisetin-doped scaffolds (BG-PCL-Fis) has been highlighted by in vitro and in vivo studies. A positive impact is demonstrated on the adhesion and the differentiation of rat primary osteoblasts, without an adverse cytotoxic effect. Implantation in critical-size mouse calvaria defects shows bone remodeling characteristics and remarkable enhancement of bone regeneration for fisetin-doped scaffolds, with the regenerated bone volume being twofold that of nondoped scaffolds and fourfold that of a commercial trabecular bovine bone substitute. Such highly bioactive materials could stand as competitive alternative strategies involving biomaterials loaded with growth factors, the use of the latter being the subject of growing concerns.


  • Mechanism of Calcium Incorporation Inside Sol–Gel Silicate Bioactive Glass and the Advantage of Using Ca(OH)2 over Other Calcium Sources

    by Cédric Bossard, Henri Granel, Édouard Jallot, Valérie Montouillout, Franck Fayon, Jérémy Soulié, Christophe Drouet, Yohann Wittrant, Jonathan Lao

    Calcium is an essential component of osteogenesis and is often required for imparting significant bioactivity to synthetic bone substitutes and in particular silicate-based materials. However, the mechanism of calcium incorporation inside sol-gel silicates is poorly understood. In this work, we shed light on the determinant parameters for incorporation of calcium into acid-base catalysed sol-gel silicates at ambient temperature: increasing the pH above the isoelectric point (IEP) of silicic acid and the nature of the calcium counterion in the calcium precursor are found to be the key. Based on our proposed reaction sequence, we were able to compare calcium precursors and select an ideal candidate compound for the synthesis of bioactive glasses (BG) and organic-inorganic hybrids at ambient temperature. Reproducible syntheses and gel times of SiO2-CaO BG were obtained using calcium hydroxide (CH), and we demonstrate its usability in the synthesis of promising BG-polycaprolactone (PCL) hybrid scaffolds. BG and hybrids prepared with CH were able to form nanocrystalline non-stoichiometric apatite in Simulated Body Fluid (SBF). The increased reliability of low temperature syntheses associated to the use of a stable and inexpensive alkaline-earth precursor are major steps towards the translation of calcium silicate hybrids or other alkaline-earth silicates from bench to clinic.


  • Bioactive Glass/Polycaprolactone Hybrid with a Dual Cortical/Trabecular Structure for Bone Regeneration

    by Henri Granel, Cédric Bossard, Anne-Margaux Collignon, Fabien Wauquier, Julie Lesieur, Gael Y Rochefort, Edouard Jallot, Jonathan Lao, Yohann Wittrant

    Organic–inorganic hybrid biomaterials stand as a promise for combining bone bonding and bone mineral-forming ability, stimulation of osteogenic cells, and adequate mechanical properties. Bioactive glass (BG)–polycaprolactone (PCL) hybrids are of special interest as they gather the ability of BG to enhance osteoblast-mediated bone formation with the slow degradation rate and the toughness of PCL. In this study, BG-PCL hybrids were synthesized in the form of scaffold, owing to a dual cortical/trabecular structure mimicking the bone architecture. Their biological potential was evaluated both in vitro using rat primary osteoblasts (RPO) and in vivo in a mice model of critical-size calvarial defects. BG-PCL scaffolds were compared to Lubboc (BTB), a commercial purified bovine xenograft widely used in orthopedics and periodontal procedures and known for its efficiency. BG-PCL hybrids were found to facilitate RPO adhesion at their surface and to enhance RPO differentiation when compared to BTB. An in vivo micro-CT study demonstrates a higher bone ingrowth with BG-PCL scaffolds and a complete chemical conversion of the remaining BG-PCL after 3 months of implantation, while histological data show the vascularization of BG-PCL scaffolds and confirm the well-advanced bone regeneration with ongoing remodeling. Finally, we evidence the complete chemical conversion of the remaining BG-PCL into a bone-like mineral.